Sartorius, 102000003, in vivo-jetPEI® GMP

in vivo-jetPEI® is a ready-to-use cationic polymer reagent recommended for in vivo transfection of nucleic acids (DNA, siRNA, miRNA, shRNA and other oligonucleotides) in any animal model.

With more than 600 publications, in vivo-jetPEI® is established in the field of in vivo delivery, whether for functional studies, oncology research as well as vaccination purposes.
Additionally, in vivo-jetPEI® has the advantage of being available in 2 different quality grades (Research-grade and GMP) to support our customers at each step of their development process.
Key Benefits:
Time-Saving: Ready-to-use reagent that does not require formulation equipment.
GMP Grade Availability: Manufactured according to both US (21CFR parts 210 and 211) and EU Guidelines (Eudralex Vol 4).
Successful: Excipient for in vivo delivery widely used from fundamental research to Human clinical trials.
Reliability and Regulatory Compliance: Chemically defined and animal derived component free.
Renowned: Well-documented in vivo transfection technology with over 600 peer-reviewed publications

Specifications
Applications:
Application: in vivo delivery of nucleic acids (DNA, siRNA/miRNA, oligonucleotides)

Biological Information:
Biodistribution & Injection routes: Universal biodistribution: Any organ or tissue (depending on the injection route)
Molecule delivered: DNA, siRNA, miRNA, shRNA, mRNA, saRNA or other oligonucleotides
Number of injections in mice: 100 µl of in vivo-jetPEI® is sufficient to perform 15 to 25 intravenous injections or 60 to 80 intratumoral injections in mice

Compliance Information:
GMP Compliance: Yes
Product Documentation: Certificate of compliance; Drug master file; Quality agreement

General Specifications:
Amount of Reagent: in vivo-jetPEI® GMP powder 10 g
Reagents and Kits Type: in vivo-jetPEI®

Product Information:
Provided With: Glucose solution

Storage Conditions:
Storage Conditions: -20 °C ± 5 °C